NCT01010919

Brief Summary

Extracts of chicory root have anti-inflammatory properties in vitro and in animal models of arthritis. The primary objective of this investigator-initiated, Phase 1, placebo-controlled, double blind, dose-escalating trial is to determine the safety and tolerability of a proprietary bioactive extract of chicory root in patients with osteoarthritis (OA). Secondary objectives are to assess effects on the signs and symptoms of this disorder. Individuals greater than 50 years of age with OA of the hip or knee will be eligible for trial entry.

Trial Health

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 10, 2009

Completed
Last Updated

November 10, 2009

Status Verified

November 1, 2009

First QC Date

November 6, 2009

Last Update Submit

November 9, 2009

Conditions

Interventions

Chicory root extractDIETARY_SUPPLEMENT

Eligibility Criteria

Age50 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must be 50 years of age or older and may be of either gender.
  • Patients must have have an imaging-confirmed (radiograph or MRI) diagnosis of OA of the hip or knee.
  • Patients must not have taken a nonsteroidal anti-inflammatory medication for at least 7 days prior to the baseline visit (a single daily aspirin 325 mg or less is allowed throughout the study).
  • Patients must be able and willing to give informed consent.

You may not qualify if:

  • Any unstable comorbid medical condition that in the opinion of the investigator could interfere with the ability of the patient to complete the study.
  • Patients who are unable to ambulate and require a wheelchair due to the severity of the arthritis are excluded. Ambulatory aids such as canes and walkers are acceptable.
  • Patients requiring continuing therapy with nonsteroidal anti-inflammatory drugs are excluded.
  • Patients requiring any dose of glucocorticoids within the past 30 days are excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Olsen NJ, Branch VK, Jonnala G, Seskar M, Cooper M. Phase 1, placebo-controlled, dose escalation trial of chicory root extract in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord. 2010 Jul 9;11:156. doi: 10.1186/1471-2474-11-156.

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
interventional
Phase
phase 1
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 6, 2009

First Posted

November 10, 2009

Last Updated

November 10, 2009

Record last verified: 2009-11